Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Garmo

Showing results (221-230 of 261) with videos related to

Pageof 27
Sort By:
Oncotarget|February 9, 2018
Thyroid cancer risk in the Swedish AMORIS study: the role of inflammatory biomarkers in serumArunangshu Ghoshal, Hans Garmo, Rhonda Arthur, et al.
Plos One|February 2, 2013
Serum glucose and fructosamine in relation to risk of cancerWahyu Wulaningsih, Lars Holmberg, Hans Garmo, et al.
European Urology|July 31, 2025
Time Dependence of Outcomes in the SPCG-4 Randomized Trial Comparing Radical Prostatectomy and Watchful Waiting in Early Prostate CancerLars Holmberg, Hans Garmo, Sven-Olov Andersson, et al.
Leukemia Research|October 28, 2018
Leukemic transformation and second cancers in 3649 patients with high-risk essential thrombocythemia in the EXELS studyGunnar Birgegård, Folke Folkvaljon, Hans Garmo, et al.
European Urology Oncology|January 17, 2024
Patient-reported Side Effects 1 Year After Radical Prostatectomy or Radiotherapy for Prostate Cancer: A Register-based Nationwide StudyChristian Corsini, Oskar Bergengren, Stefan Carlsson, et al.
Breast Cancer Research and Treatment|September 15, 2016
Long-term outcome in young women with breast cancer: a population-based studyHanna Fredholm, Kristina Magnusson, Linda S Lindström, et al.
Breast (Edinburgh, Scotland)|January 26, 2020
Invasive breast cancer over four decades reveals persisting poor metastatic outcomes in treatment resistant subgroup - the "ATRESS" phenomenonPatriek Jurrius, Thomas Green, Hans Garmo, et al.
Scandinavian Journal of Urology and Nephrology|July 16, 2005
The National Prostate Cancer Register in Sweden 1998-2002: trends in incidence, treatment and survivalEberhard Varenhorst, Hans Garmo, Lars Holmberg, et al.
BJU International|April 15, 2024
Population-based study of disease trajectory after radical treatment for high-risk prostate cancerPär Stattin, Sarah Fleming, Xiwu Lin, et al.
Cancer Medicine|March 1, 2016
Association between baseline serum glucose, triglycerides and total cholesterol, and prostate cancer risk categoriesRhonda Arthur, Henrik Møller, Hans Garmo, et al.
Pageof 27

Showing results (221-230 of 261) with videos related to

Sort By:
Pageof 27
Oncotarget|February 9, 2018
Thyroid cancer risk in the Swedish AMORIS study: the role of inflammatory biomarkers in serumArunangshu Ghoshal, Hans Garmo, Rhonda Arthur, et al.
Plos One|February 2, 2013
Serum glucose and fructosamine in relation to risk of cancerWahyu Wulaningsih, Lars Holmberg, Hans Garmo, et al.
European Urology|July 31, 2025
Time Dependence of Outcomes in the SPCG-4 Randomized Trial Comparing Radical Prostatectomy and Watchful Waiting in Early Prostate CancerLars Holmberg, Hans Garmo, Sven-Olov Andersson, et al.
Leukemia Research|October 28, 2018
Leukemic transformation and second cancers in 3649 patients with high-risk essential thrombocythemia in the EXELS studyGunnar Birgegård, Folke Folkvaljon, Hans Garmo, et al.
European Urology Oncology|January 17, 2024
Patient-reported Side Effects 1 Year After Radical Prostatectomy or Radiotherapy for Prostate Cancer: A Register-based Nationwide StudyChristian Corsini, Oskar Bergengren, Stefan Carlsson, et al.
Breast Cancer Research and Treatment|September 15, 2016
Long-term outcome in young women with breast cancer: a population-based studyHanna Fredholm, Kristina Magnusson, Linda S Lindström, et al.
Breast (Edinburgh, Scotland)|January 26, 2020
Invasive breast cancer over four decades reveals persisting poor metastatic outcomes in treatment resistant subgroup - the "ATRESS" phenomenonPatriek Jurrius, Thomas Green, Hans Garmo, et al.
Scandinavian Journal of Urology and Nephrology|July 16, 2005
The National Prostate Cancer Register in Sweden 1998-2002: trends in incidence, treatment and survivalEberhard Varenhorst, Hans Garmo, Lars Holmberg, et al.
BJU International|April 15, 2024
Population-based study of disease trajectory after radical treatment for high-risk prostate cancerPär Stattin, Sarah Fleming, Xiwu Lin, et al.
Cancer Medicine|March 1, 2016
Association between baseline serum glucose, triglycerides and total cholesterol, and prostate cancer risk categoriesRhonda Arthur, Henrik Møller, Hans Garmo, et al.
Pageof 27